Cover Image
Market Research Report

Trichuriasis Global Clinical Trials Review, H2, 2018

Published by GlobalData Product code 321247
Published Content info 36 Pages
Delivery time: 1-2 business days
Price
Back to Top
Trichuriasis Global Clinical Trials Review, H2, 2018
Published: September 28, 2018 Content info: 36 Pages
Description

GlobalData's clinical trial report, "Trichuriasis Global Clinical Trials Review, H2, 2018" provides an overview of Trichuriasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trichuriasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
Product Code: GDHC5251CTIDB

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Trichuriasis to Infectious Disease Clinical Trials 14
  • Clinical Trials by E7 Countries: Proportion of Trichuriasis to Infectious Disease Clinical Trials 15
  • Clinical Trials by Phase 16
  • Clinical Trials by Trial Status 17
  • Clinical Trials by End Point Status 19
  • Subjects Recruited Over a Period of Time 20
  • Clinical Trials by Sponsor Type 21
  • Prominent Sponsors 22
  • Top Companies Participating in Trichuriasis Therapeutics Clinical Trials 23
  • Clinical Trial Profile Snapshots 24

Appendix 34

  • Abbreviations 34
  • Definitions 34
  • Research Methodology 35
  • Secondary Research 35
  • About GlobalData 35
  • Contact Us 36
  • Source 36

List of Tables

  • Trichuriasis Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Trichuriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Trichuriasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 10
  • Trichuriasis Therapeutics Clinical Trials, Europe, Top Countries, 2018* 11
  • Trichuriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12
  • Trichuriasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 13
  • Proportion of Trichuriasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 14
  • Proportion of Trichuriasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 15
  • Trichuriasis Therapeutics, Global, Clinical Trials by Phase, 2018* 16
  • Trichuriasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 18
  • Trichuriasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 19
  • Trichuriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
  • Trichuriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 21
  • Trichuriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
  • Trichuriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23

List of Figures

  • Trichuriasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Trichuriasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Trichuriasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 10
  • Trichuriasis Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 11
  • Trichuriasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 12
  • Trichuriasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 13
  • Proportion of Trichuriasis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 14
  • Proportion of Trichuriasis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 15
  • Trichuriasis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 16
  • Trichuriasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 17
  • Trichuriasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 20
  • Trichuriasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 21
  • Trichuriasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 22
  • Trichuriasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 23
  • GlobalData Methodology 35
Back to Top